Inclacumab was generally well tolerated in THRIVE-131
Currently focused on platform-related queries, elva.AI is the first step in ekincare’s broader roadmap
The system, called GeneAgent, cross-checks its own initial predictions for accuracy against information from established, expert-curated databases
Trixeo is the first pMDI medicine in AstraZeneca’s portfolio to use the near-zero GWP propellant
This achievement is part of the population-based initiative for screening, prevention, and management of Non-Communicable Diseases
Akums bridges the long-standing gap between paediatric syrups and conventional tablet formats
Shelcal Total marks the brand’s evolution into a modern, consumer-focused nutrition portfolio
Subscribe To Our Newsletter & Stay Updated